Conduent(CNDT) - 2025 Q3 - Earnings Call Transcript

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $767 million, slightly up sequentially and in line with guidance, but down 1.8% year-over-year from $781 million in Q3 2024 [11][12] - Adjusted EBITDA for the quarter was $40 million, up from $32 million in Q3 2024, with an adjusted EBITDA margin of 5.2%, up 110 basis points year-over-year [12][14] - The net leverage ratio increased to 3.2x due to cash flow items, with adjusted free cash flow for the quarter at -$54 million [15][17] Business Line Data and Key Metrics Changes - The commercial segment adjusted revenue was $367 million, down 4.7% year-over-year, primarily due to volume declines from the largest client [12][13] - Government segment adjusted revenue was down 6.7% at $238 million, attributed to implementation impacts and a client canceling an implementation [13] - Transportation segment adjusted revenue increased by 14.9% year-over-year to $162 million, driven by strong equipment sales [14] Market Data and Key Metrics Changes - New business Annual Contract Value (ACV) signed in the quarter was $111 million, consistent with the prior year, while year-to-date new business ACV was up 5% [10] - The qualified ACV pipeline remains strong at $3.4 billion, up 9% year-over-year, driven by government segment opportunities [11] Company Strategy and Development Direction - The company is focused on portfolio rationalization and enhancing its technology capabilities, particularly in AI initiatives [8][19] - A new board member with significant industry experience has been added to strengthen the board [8] - The company is revising its commercial go-to-market strategy to improve client penetration and sales execution [21] Management's Comments on Operating Environment and Future Outlook - Management noted the impact of the federal government shutdown on deal timing but expressed confidence in achieving adjusted EBITDA margin targets [18][20] - The company anticipates that once the shutdown concerns are resolved, cash flow metrics will improve [7][18] - Management remains optimistic about future growth, citing pent-up demand and ongoing sales pipeline expansion [21][23] Other Important Information - The company has refinanced its revolving credit facility, simplifying its balance sheet [7][15] - AI initiatives are being deployed to enhance operational efficiency and reduce fraud, particularly in government programs [22] Q&A Session Summary Question: How much of the pipeline actually closed this quarter? - Management indicated that the government shutdown has delayed some deals, but they expect a gradual release of opportunities as the situation normalizes [29] Question: How is productivity or quality gains from GenAI being measured? - The primary pilot in the government space focuses on fraud reduction, with expectations of spreading these capabilities across Medicaid and SNAP environments [30][31] Question: Are there any specific costs left to tackle from stranded costs? - Management stated that they are through the initial phase of stranded costs and are continuously optimizing costs across the organization [35] Question: Are there changes to contract clauses to reduce churn risk? - Management confirmed that the revenue stream remains unaffected by the government shutdown, and no changes to the contract model are currently planned [36] Question: What does the client mix look like for AI endeavors? - The commercial space has a significant focus on healthcare, while the government space targets Medicaid processing for fraud reduction [44] Question: What are the growth opportunities on the commercial side? - Management is focused on increasing product penetration within existing clients and enhancing the sales pipeline to support growth [46][47]